This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Avidus Announces Launch Of Asantae IS2™ Functional Beverage

VANCOUVER, BC and MESA, AZ, Oct. 17, 2013 /PRNewswire/ - Avidus Management Group Inc. (" Avidus" or the " Company") (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary Asantae is pleased to announce that IS2™, a proprietary new functional beverage is now shipping from all company warehouse locations.

Company President, Doug Ridley said, "Ninety days ago we promised a new Asantae and this week we delivered on those promises with the launch of this powerful functional beverage, a dynamic new website ( www.asantae.com), two new product videos, and a new business presentation video.  It's an exciting time at Asantae as we roll out all these improvements and enhancements.  We look forward to an even greater future ahead as the benefits accrue to the company."

According to MarketResearch.com, the functional beverage market had total revenues that exceeded $25 bn in 2012 and annual compounded growth rates of 6% per year for the trailing 5-years.   The market is projected to grow to over $38 bn by 2017.

Asantae's formulation team created IS2™ to support the body's natural immune system and inflammatory response.  These natural systems function best when they quickly and completely "Recognize, Respond, and Resolve" threats, invasions, infections and injuries in the body.  IS2™ is specifically formulated to help these systems function optimally.  Among many other ingredients to be discussed in more detailed news, IS2™ features Wellmune™, a powerful new compound with significant research behind it ( www.wellmune.com).

"Not only does IS2™ have tremendous health benefits, but it also will dramatically improve our overall gross margins," said Dan Lundell, CEO.  He further pointed out, "With comparable margins, IS2™ is an ideal companion to our groundbreaking weight-loss product RealW8™.  It has 300% better margins than two of our legacy products.  Beyond the obvious benefits of higher gross margins, enabling improved commissions drives recruiting growth and momentum."

Leading distributor Erik Cloud said, "As a full-time network marketing professional who has built my entire career around functional beverages, this is the  most functional health beverage I've ever seen.  I can build a massive organization in a relatively short time with a product that tastes this good, has benefits that people feel, and is easy for distributors like me to share.  The availability of this product at Asantae unleashes a new and powerful phase of recruiting, broadening the audience to other professional networkers who have achieved huge success with functional beverages; our timing could not be better."

About Avidus

Avidus Management Group Inc. (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary, Asantae, Inc. ( www.asantae.com) develops, produces and markets innovative nutritional products through direct and network marketing channels.  The ingredients in Asantae's products have been shown to reduce chronic low-grade inflammation and oxidative stress, and support a healthy immune system that, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (diabetes, heart disease, obesity, stroke, etc.). 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,691.88 -26.66 -0.15%
S&P 500 2,058.81 -2.24 -0.11%
NASDAQ 4,866.6760 -9.8430 -0.20%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs